| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ COL21A1 COL27A1 | 3.39e-30 | 46 | 31 | 14 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A1 AMBN COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ COL21A1 COL27A1 | 6.05e-23 | 188 | 31 | 15 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A1 AMBN COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ COL21A1 COL27A1 | 7.59e-13 | 891 | 31 | 15 | GO:0005198 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A1 AMBN COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ COL27A1 | 4.08e-17 | 377 | 30 | 14 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A1 AMBN COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ COL27A1 | 4.23e-17 | 378 | 30 | 14 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A1 AMBN COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ COL27A1 | 4.39e-17 | 379 | 30 | 14 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.78e-09 | 12 | 30 | 4 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 1.10e-08 | 18 | 30 | 4 | GO:0038065 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 2.04e-04 | 79 | 30 | 3 | GO:0060350 | |
| GeneOntologyCellularComponent | collagen trimer | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ COL21A1 MARCO COL27A1 | 1.87e-28 | 88 | 31 | 15 | GO:0005581 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 AMBN COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ RELL2 COL21A1 MARCO COL27A1 | 3.99e-18 | 656 | 31 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 AMBN COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ RELL2 COL21A1 MARCO COL27A1 | 4.20e-18 | 658 | 31 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ RELL2 COL21A1 MARCO COL27A1 | 4.93e-18 | 530 | 31 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL4A1 AMBN COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.03e-17 | 332 | 31 | 14 | GO:0005788 |
| GeneOntologyCellularComponent | complex of collagen trimers | 8.72e-16 | 21 | 31 | 7 | GO:0098644 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.85e-13 | 8 | 31 | 5 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.85e-13 | 8 | 31 | 5 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 5.92e-11 | 6 | 31 | 4 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 2.76e-10 | 8 | 31 | 4 | GO:0098651 | |
| GeneOntologyCellularComponent | basement membrane | 4.54e-10 | 122 | 31 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.39e-04 | 12 | 31 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.39e-04 | 12 | 31 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.48e-03 | 1187 | 31 | 7 | GO:0099081 | |
| MousePheno | abnormal basement membrane morphology | 8.21e-07 | 40 | 26 | 4 | MP:0004272 | |
| MousePheno | buphthalmos | 1.99e-05 | 4 | 26 | 2 | MP:0009274 | |
| MousePheno | abnormal extracellular matrix morphology | 3.27e-05 | 100 | 26 | 4 | MP:0013258 | |
| MousePheno | anterior polar cataract | 3.32e-05 | 5 | 26 | 2 | MP:0010259 | |
| MousePheno | podocyte foot process effacement | 4.61e-05 | 38 | 26 | 3 | MP:0008140 | |
| MousePheno | polar cataract | 4.97e-05 | 6 | 26 | 2 | MP:0010258 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 7.19e-05 | 44 | 26 | 3 | MP:0011348 | |
| MousePheno | macrophthalmia | 9.25e-05 | 8 | 26 | 2 | MP:0001296 | |
| MousePheno | abnormal podocyte foot process morphology | 1.41e-04 | 55 | 26 | 3 | MP:0008059 | |
| MousePheno | total cataract | 2.56e-04 | 13 | 26 | 2 | MP:0010263 | |
| MousePheno | abnormal podocyte morphology | 2.88e-04 | 70 | 26 | 3 | MP:0005326 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 2.88e-04 | 70 | 26 | 3 | MP:0011497 | |
| MousePheno | hematuria | 5.58e-04 | 19 | 26 | 2 | MP:0005161 | |
| MousePheno | postnatal lethality | 5.62e-04 | 1084 | 26 | 8 | MP:0002082 | |
| MousePheno | lens vacuoles | 6.19e-04 | 20 | 26 | 2 | MP:0011697 | |
| Domain | Collagen | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ COL21A1 MARCO COL27A1 | 5.72e-28 | 85 | 31 | 15 | PF01391 |
| Domain | Collagen | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ COL21A1 MARCO COL27A1 | 5.72e-28 | 85 | 31 | 15 | IPR008160 |
| Domain | C4 | 9.29e-11 | 6 | 31 | 4 | SM00111 | |
| Domain | - | 9.29e-11 | 6 | 31 | 4 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 9.29e-11 | 6 | 31 | 4 | IPR001442 | |
| Domain | NC1_IV | 9.29e-11 | 6 | 31 | 4 | PS51403 | |
| Domain | C4 | 9.29e-11 | 6 | 31 | 4 | PF01413 | |
| Domain | TSPN | 5.38e-08 | 23 | 31 | 4 | SM00210 | |
| Domain | Fib_collagen_C | 6.77e-07 | 11 | 31 | 3 | IPR000885 | |
| Domain | NC1_FIB | 6.77e-07 | 11 | 31 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 6.77e-07 | 11 | 31 | 3 | PD002078 | |
| Domain | COLFI | 6.77e-07 | 11 | 31 | 3 | SM00038 | |
| Domain | COLFI | 6.77e-07 | 11 | 31 | 3 | PF01410 | |
| Domain | Laminin_G | 2.47e-06 | 58 | 31 | 4 | IPR001791 | |
| Domain | SSDP_DNA-bd | 7.99e-06 | 3 | 31 | 2 | IPR008116 | |
| Domain | CTDL_fold | 2.84e-05 | 107 | 31 | 4 | IPR016187 | |
| Domain | ConA-like_dom | 4.51e-04 | 219 | 31 | 4 | IPR013320 | |
| Domain | LisH | 9.81e-04 | 28 | 31 | 2 | IPR006594 | |
| Domain | LISH | 9.81e-04 | 28 | 31 | 2 | PS50896 | |
| Domain | LisH | 9.81e-04 | 28 | 31 | 2 | SM00667 | |
| Domain | LAM_G_DOMAIN | 1.81e-03 | 38 | 31 | 2 | PS50025 | |
| Domain | TF_fork_head_CS_2 | 2.64e-03 | 46 | 31 | 2 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 2.75e-03 | 47 | 31 | 2 | IPR018122 | |
| Domain | FORK_HEAD_3 | 2.99e-03 | 49 | 31 | 2 | PS50039 | |
| Domain | FH | 2.99e-03 | 49 | 31 | 2 | SM00339 | |
| Domain | FORK_HEAD_1 | 2.99e-03 | 49 | 31 | 2 | PS00657 | |
| Domain | FORK_HEAD_2 | 2.99e-03 | 49 | 31 | 2 | PS00658 | |
| Domain | Forkhead | 2.99e-03 | 49 | 31 | 2 | PF00250 | |
| Domain | Fork_head_dom | 2.99e-03 | 49 | 31 | 2 | IPR001766 | |
| Domain | VWA | 3.88e-03 | 56 | 31 | 2 | PF00092 | |
| Domain | - | 6.69e-03 | 74 | 31 | 2 | 3.40.50.410 | |
| Domain | VWFA | 8.15e-03 | 82 | 31 | 2 | PS50234 | |
| Domain | VWA | 8.54e-03 | 84 | 31 | 2 | SM00327 | |
| Domain | - | 1.08e-02 | 95 | 31 | 2 | 2.60.120.200 | |
| Domain | VWF_A | 1.17e-02 | 99 | 31 | 2 | IPR002035 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.90e-27 | 44 | 25 | 13 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 9.12e-25 | 67 | 25 | 13 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 5.80e-23 | 90 | 25 | 13 | M631 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 | 4.18e-20 | 41 | 25 | 10 | MM15538 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL27A1 | 3.30e-18 | 61 | 25 | 10 | M27103 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 | 3.30e-18 | 61 | 25 | 10 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 | 3.44e-17 | 76 | 25 | 10 | MM14573 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 5.87e-16 | 300 | 25 | 13 | M610 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL9A2 COL10A1 COL13A1 COL17A1 | 8.80e-16 | 64 | 25 | 9 | M26953 |
| Pathway | PID_SYNDECAN_1_PATHWAY | 7.02e-15 | 46 | 25 | 8 | M198 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 3.93e-13 | 74 | 25 | 8 | M160 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.24e-12 | 85 | 25 | 8 | M16441 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL9A2 COL10A1 COL13A1 COL17A1 | 1.29e-12 | 140 | 25 | 9 | M587 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.09e-12 | 50 | 25 | 7 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.21e-12 | 53 | 25 | 7 | MM14566 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 | 9.10e-12 | 258 | 25 | 10 | MM14572 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.43e-11 | 32 | 25 | 6 | MM14924 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.44e-11 | 76 | 25 | 7 | MM14867 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.75e-10 | 20 | 25 | 5 | MM15061 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.89e-10 | 59 | 25 | 6 | M27218 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.00e-10 | 114 | 25 | 7 | MM14571 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.60e-09 | 10 | 25 | 4 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.60e-09 | 10 | 25 | 4 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.52e-09 | 11 | 25 | 4 | M15422 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.28e-09 | 76 | 25 | 6 | M27219 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 3.77e-09 | 12 | 25 | 4 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 5.44e-09 | 13 | 25 | 4 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 5.44e-09 | 13 | 25 | 4 | M12950 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 5.53e-09 | 38 | 25 | 5 | MM14969 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 7.61e-09 | 14 | 25 | 4 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 7.61e-09 | 14 | 25 | 4 | M6487 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 9.33e-09 | 42 | 25 | 5 | M7169 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.04e-08 | 15 | 25 | 4 | M27161 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.04e-08 | 15 | 25 | 4 | MM14922 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.31e-08 | 18 | 25 | 4 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.31e-08 | 18 | 25 | 4 | MM14882 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 3.66e-08 | 20 | 25 | 4 | M15394 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.51e-08 | 57 | 25 | 5 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.93e-08 | 58 | 25 | 5 | M2049 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 6.66e-08 | 23 | 25 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 6.66e-08 | 23 | 25 | 4 | MM1427 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 7.52e-08 | 63 | 25 | 5 | M11187 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.04e-07 | 30 | 25 | 4 | M27216 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 4.69e-06 | 19 | 25 | 3 | M27221 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.15e-06 | 66 | 25 | 4 | M18 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.35e-05 | 84 | 25 | 4 | M7098 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.94e-05 | 30 | 25 | 3 | M27772 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 2.29e-05 | 96 | 25 | 4 | M39834 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.78e-05 | 532 | 25 | 7 | M27870 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.02e-05 | 41 | 25 | 3 | M27778 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 5.80e-05 | 43 | 25 | 3 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 5.80e-05 | 43 | 25 | 3 | M53 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 8.21e-05 | 261 | 25 | 5 | MM15676 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.72e-04 | 161 | 25 | 4 | M39770 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.97e-04 | 502 | 25 | 6 | MM14537 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.79e-04 | 339 | 25 | 5 | M39736 | |
| Pathway | WP_FOCAL_ADHESION | 3.05e-04 | 187 | 25 | 4 | MM15913 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.56e-04 | 79 | 25 | 3 | M27643 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.86e-04 | 199 | 25 | 4 | M7253 | |
| Pathway | WP_FOCAL_ADHESION | 3.86e-04 | 199 | 25 | 4 | M39402 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 4.27e-04 | 84 | 25 | 3 | M3228 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 6.71e-04 | 98 | 25 | 3 | M27152 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 7.28e-04 | 418 | 25 | 5 | MM15587 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.83e-03 | 302 | 25 | 4 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 2.42e-03 | 326 | 25 | 4 | MM15917 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 2.47e-03 | 1432 | 25 | 8 | M509 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.99e-03 | 575 | 25 | 5 | M29853 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.11e-03 | 47 | 25 | 2 | MM14925 | |
| Pathway | WP_RETT_SYNDROME | 3.24e-03 | 48 | 25 | 2 | M39759 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 6.98e-03 | 439 | 25 | 4 | M42563 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 7.35e-03 | 73 | 25 | 2 | MM15126 | |
| Pathway | WP_CANCER_PATHWAYS | 1.15e-02 | 507 | 25 | 4 | M48302 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 1.24e-02 | 96 | 25 | 2 | MM14592 | |
| Pubmed | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL13A1 COL17A1 COLQ COL21A1 | 4.44e-21 | 153 | 31 | 12 | 25037231 | |
| Pubmed | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL27A1 | 3.25e-16 | 175 | 31 | 10 | 28071719 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 4.87e-16 | 62 | 31 | 8 | 28344315 | |
| Pubmed | COL4A1 COL4A2 COL4A6 COL5A2 COL24A1 COL10A1 COL13A1 COLQ COL27A1 | 2.01e-14 | 167 | 31 | 9 | 22159717 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.06e-13 | 135 | 31 | 8 | 28675934 | |
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 7.73e-12 | 6 | 31 | 4 | 10534397 | |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 7.73e-12 | 6 | 31 | 4 | 9506531 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 7.73e-12 | 6 | 31 | 4 | 9673377 | |
| Pubmed | 7.73e-12 | 6 | 31 | 4 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 7.73e-12 | 6 | 31 | 4 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 7.73e-12 | 6 | 31 | 4 | 6811420 | |
| Pubmed | 7.73e-12 | 6 | 31 | 4 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 7.73e-12 | 6 | 31 | 4 | 19275937 | |
| Pubmed | 7.73e-12 | 6 | 31 | 4 | 6988303 | ||
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 7.73e-12 | 6 | 31 | 4 | 6389236 | |
| Pubmed | 7.73e-12 | 6 | 31 | 4 | 12225806 | ||
| Pubmed | 1.80e-11 | 7 | 31 | 4 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 1.80e-11 | 7 | 31 | 4 | 8006028 | |
| Pubmed | 1.80e-11 | 7 | 31 | 4 | 10416788 | ||
| Pubmed | 1.80e-11 | 7 | 31 | 4 | 1724753 | ||
| Pubmed | 3.60e-11 | 8 | 31 | 4 | 10382266 | ||
| Pubmed | 3.60e-11 | 8 | 31 | 4 | 3997552 | ||
| Pubmed | 3.60e-11 | 8 | 31 | 4 | 29422532 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 3.60e-11 | 8 | 31 | 4 | 10970885 | |
| Pubmed | 3.60e-11 | 8 | 31 | 4 | 1377218 | ||
| Pubmed | 6.48e-11 | 9 | 31 | 4 | 9878537 | ||
| Pubmed | 6.48e-11 | 9 | 31 | 4 | 12101409 | ||
| Pubmed | 1.08e-10 | 10 | 31 | 4 | 9136074 | ||
| Pubmed | 1.70e-10 | 11 | 31 | 4 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 1.70e-10 | 11 | 31 | 4 | 7500359 | |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 2.54e-10 | 12 | 31 | 4 | 15837576 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 2.54e-10 | 12 | 31 | 4 | 12180907 | |
| Pubmed | 2.54e-10 | 12 | 31 | 4 | 16024816 | ||
| Pubmed | 5.14e-10 | 14 | 31 | 4 | 12878203 | ||
| Pubmed | 6.16e-10 | 210 | 31 | 7 | 16537572 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 3025878 | ||
| Pubmed | 9.33e-10 | 16 | 31 | 4 | 15878328 | ||
| Pubmed | 1.98e-09 | 19 | 31 | 4 | 15689378 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 2.56e-09 | 4 | 31 | 3 | 7827955 | |
| Pubmed | 3.06e-09 | 21 | 31 | 4 | 23325811 | ||
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 9409248 | ||
| Pubmed | 7.61e-09 | 26 | 31 | 4 | 24742657 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 8.63e-09 | 79 | 31 | 5 | 18757743 | |
| Pubmed | 1.28e-08 | 6 | 31 | 3 | 16041630 | ||
| Pubmed | 1.28e-08 | 6 | 31 | 3 | 7495302 | ||
| Pubmed | 1.60e-08 | 31 | 31 | 4 | 22925884 | ||
| Pubmed | 2.24e-08 | 7 | 31 | 3 | 10639489 | ||
| Pubmed | 2.24e-08 | 7 | 31 | 3 | 7521231 | ||
| Pubmed | 2.24e-08 | 7 | 31 | 3 | 17418794 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 2.24e-08 | 7 | 31 | 3 | 10716744 | |
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 3.58e-08 | 8 | 31 | 3 | 11867580 | |
| Pubmed | 4.61e-08 | 40 | 31 | 4 | 27068110 | ||
| Pubmed | Collagen XXVII organises the pericellular matrix in the growth plate. | 5.37e-08 | 9 | 31 | 3 | 22206015 | |
| Pubmed | 5.37e-08 | 9 | 31 | 3 | 8562707 | ||
| Pubmed | 5.37e-08 | 9 | 31 | 3 | 10880400 | ||
| Pubmed | 5.37e-08 | 9 | 31 | 3 | 8995276 | ||
| Pubmed | 7.66e-08 | 10 | 31 | 3 | 9415455 | ||
| Pubmed | Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressor. | 1.05e-07 | 11 | 31 | 3 | 17339318 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 1.05e-07 | 11 | 31 | 3 | 9731539 | |
| Pubmed | 1.40e-07 | 12 | 31 | 3 | 8918877 | ||
| Pubmed | 1.40e-07 | 12 | 31 | 3 | 26794322 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 1.82e-07 | 13 | 31 | 3 | 9833687 | |
| Pubmed | 2.32e-07 | 14 | 31 | 3 | 19858219 | ||
| Pubmed | 2.90e-07 | 15 | 31 | 3 | 10625553 | ||
| Pubmed | 2.90e-07 | 15 | 31 | 3 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 2.90e-07 | 15 | 31 | 3 | 10706142 | |
| Pubmed | 3.56e-07 | 16 | 31 | 3 | 17881772 | ||
| Pubmed | 5.18e-07 | 18 | 31 | 3 | 9160753 | ||
| Pubmed | TIF1gamma controls erythroid cell fate by regulating transcription elongation. | 5.18e-07 | 18 | 31 | 3 | 20603019 | |
| Pubmed | 6.29e-07 | 186 | 31 | 5 | 20452482 | ||
| Pubmed | 6.29e-07 | 186 | 31 | 5 | 20673868 | ||
| Pubmed | ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. | 7.23e-07 | 20 | 31 | 3 | 16407974 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 3597383 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 17179069 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 3200851 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 32515830 | ||
| Pubmed | Sequence variants in COL4A1 and COL4A2 genes in Ecuadorian families with keratoconus. | 7.69e-07 | 2 | 31 | 2 | 21527998 | |
| Pubmed | COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. | 7.69e-07 | 2 | 31 | 2 | 22209247 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 39216230 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 22914737 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 24317722 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 31331924 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 26006016 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 30351356 | ||
| Pubmed | Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. | 7.69e-07 | 2 | 31 | 2 | 15905400 | |
| Pubmed | Specific hybridization probes for mouse alpha 2(IX) and alpha 1(X) collagen mRNAs. | 7.69e-07 | 2 | 31 | 2 | 1543751 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 24203695 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 3198626 | ||
| Pubmed | Intracerebral hemorrhage in a neonate with an intragenic COL4A2 duplication. | 7.69e-07 | 2 | 31 | 2 | 33247988 | |
| Pubmed | The direct binding of collagen XVII and collagen IV is disrupted by pemphigoid autoantibodies. | 7.69e-07 | 2 | 31 | 2 | 30089857 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 32413593 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 11970952 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 1630813 | ||
| Pubmed | Further refinement of COL4A1 and COL4A2 related cortical malformations. | 7.69e-07 | 2 | 31 | 2 | 30315939 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 26209635 | ||
| Pubmed | Prenatal clinical manifestations in individuals with COL4A1/2 variants. | 7.69e-07 | 2 | 31 | 2 | 32732225 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 33148145 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 12011424 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 2846280 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 3182844 | ||
| Interaction | PLOD3 interactions | COL4A1 COL4A2 COL4A6 COL9A2 COL13A1 COL17A1 COLQ COL21A1 MARCO | 5.85e-12 | 183 | 31 | 9 | int:PLOD3 |
| Interaction | COLGALT2 interactions | 8.03e-12 | 67 | 31 | 7 | int:COLGALT2 | |
| Interaction | LAIR2 interactions | 1.06e-10 | 49 | 31 | 6 | int:LAIR2 | |
| Interaction | COL4A2 interactions | 1.48e-09 | 75 | 31 | 6 | int:COL4A2 | |
| Interaction | HABP2 interactions | 1.38e-08 | 18 | 31 | 4 | int:HABP2 | |
| Interaction | OSM interactions | 2.18e-08 | 20 | 31 | 4 | int:OSM | |
| Interaction | FBLN2 interactions | 5.14e-08 | 66 | 31 | 5 | int:FBLN2 | |
| Interaction | CD93 interactions | 6.53e-07 | 45 | 31 | 4 | int:CD93 | |
| Interaction | C1QTNF1 interactions | 7.80e-07 | 47 | 31 | 4 | int:C1QTNF1 | |
| Interaction | SERPINE2 interactions | 1.59e-06 | 56 | 31 | 4 | int:SERPINE2 | |
| Interaction | MMP9 interactions | 3.28e-06 | 67 | 31 | 4 | int:MMP9 | |
| Interaction | PLOD1 interactions | 4.77e-06 | 292 | 31 | 6 | int:PLOD1 | |
| Interaction | TGFBI interactions | 7.41e-06 | 25 | 31 | 3 | int:TGFBI | |
| Interaction | MMP2 interactions | 9.33e-06 | 87 | 31 | 4 | int:MMP2 | |
| Interaction | MATN2 interactions | 2.62e-05 | 113 | 31 | 4 | int:MATN2 | |
| Interaction | TBXT interactions | 2.91e-05 | 116 | 31 | 4 | int:TBXT | |
| Interaction | DCN interactions | 3.90e-05 | 43 | 31 | 3 | int:DCN | |
| Interaction | NID1 interactions | 5.44e-05 | 48 | 31 | 3 | int:NID1 | |
| Interaction | BMP3 interactions | 6.38e-05 | 8 | 31 | 2 | int:BMP3 | |
| Interaction | LHX8 interactions | 7.33e-05 | 53 | 31 | 3 | int:LHX8 | |
| Interaction | SAA1 interactions | 7.75e-05 | 54 | 31 | 3 | int:SAA1 | |
| Interaction | COL21A1 interactions | 8.19e-05 | 9 | 31 | 2 | int:COL21A1 | |
| Interaction | LHX4 interactions | 1.17e-04 | 166 | 31 | 4 | int:LHX4 | |
| Interaction | TLX1 interactions | 1.44e-04 | 175 | 31 | 4 | int:TLX1 | |
| Interaction | ACHE interactions | 1.50e-04 | 12 | 31 | 2 | int:ACHE | |
| Interaction | PLOD2 interactions | 1.60e-04 | 180 | 31 | 4 | int:PLOD2 | |
| Interaction | VHL interactions | 1.84e-04 | 561 | 31 | 6 | int:VHL | |
| Interaction | IDI2 interactions | 2.06e-04 | 14 | 31 | 2 | int:IDI2 | |
| Interaction | CBFA2T3 interactions | 2.32e-04 | 78 | 31 | 3 | int:CBFA2T3 | |
| Interaction | FN1 interactions | 2.47e-04 | 848 | 31 | 7 | int:FN1 | |
| Interaction | TAL1 interactions | 3.89e-04 | 93 | 31 | 3 | int:TAL1 | |
| Interaction | HSPG2 interactions | 4.54e-04 | 98 | 31 | 3 | int:HSPG2 | |
| Interaction | SS18L1 interactions | 4.54e-04 | 98 | 31 | 3 | int:SS18L1 | |
| Interaction | LHX1 interactions | 5.25e-04 | 103 | 31 | 3 | int:LHX1 | |
| Interaction | SLF1 interactions | 7.27e-04 | 26 | 31 | 2 | int:SLF1 | |
| Cytoband | 13q34 | 6.18e-04 | 54 | 31 | 2 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 1.63e-03 | 88 | 31 | 2 | chr13q34 | |
| GeneFamily | Collagens | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.21e-30 | 46 | 20 | 13 | 490 |
| GeneFamily | Forkhead boxes | 1.02e-03 | 43 | 20 | 2 | 508 | |
| Coexpression | NABA_COLLAGENS | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.38e-29 | 44 | 31 | 13 | M3005 |
| Coexpression | NABA_COLLAGENS | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL27A1 | 9.68e-27 | 43 | 31 | 12 | MM17060 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 AMBN COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ COL21A1 COL27A1 | 3.62e-22 | 275 | 31 | 15 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 AMBN COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ COL27A1 | 2.45e-20 | 270 | 31 | 14 | MM17057 |
| Coexpression | NABA_MATRISOME | COL4A1 AMBN COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ COL21A1 COL27A1 | 1.17e-13 | 1026 | 31 | 15 | M5889 |
| Coexpression | NABA_MATRISOME | COL4A1 AMBN COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COLQ COL27A1 | 2.04e-12 | 1008 | 31 | 14 | MM17056 |
| Coexpression | GU_PDEF_TARGETS_UP | 2.22e-10 | 71 | 31 | 6 | M3955 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.05e-09 | 40 | 31 | 5 | M5887 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 2.10e-07 | 44 | 31 | 4 | M18274 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 2.71e-07 | 385 | 31 | 7 | M39264 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.17e-06 | 479 | 31 | 7 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.24e-06 | 483 | 31 | 7 | MM1082 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 1.67e-06 | 505 | 31 | 7 | M39167 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.74e-06 | 74 | 31 | 4 | M13547 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 2.50e-06 | 81 | 31 | 4 | M39253 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.61e-06 | 23 | 31 | 3 | M48001 | |
| Coexpression | GSE17721_0.5H_VS_12H_LPS_BMDC_DN | 3.47e-06 | 199 | 31 | 5 | M4069 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.19e-05 | 120 | 31 | 4 | M42505 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 1.55e-05 | 41 | 31 | 3 | M47988 | |
| Coexpression | CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL | 1.55e-05 | 41 | 31 | 3 | M39320 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 1.71e-05 | 721 | 31 | 7 | M1999 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.34e-05 | 47 | 31 | 3 | M7585 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 2.50e-05 | 48 | 31 | 3 | M10253 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 2.50e-05 | 48 | 31 | 3 | MM1088 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 3.88e-05 | 162 | 31 | 4 | M45037 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 5.41e-05 | 352 | 31 | 5 | M17471 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 5.48e-05 | 177 | 31 | 4 | M39245 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 7.13e-05 | 68 | 31 | 3 | M1373 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 7.52e-05 | 192 | 31 | 4 | M42501 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 7.83e-05 | 194 | 31 | 4 | M39122 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP | 8.31e-05 | 197 | 31 | 4 | M5250 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 8.45e-05 | 72 | 31 | 3 | MM1131 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP | 8.64e-05 | 199 | 31 | 4 | M8371 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP | 8.64e-05 | 199 | 31 | 4 | M6235 | |
| Coexpression | GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP | 8.81e-05 | 200 | 31 | 4 | M9348 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN | 8.81e-05 | 200 | 31 | 4 | M5156 | |
| Coexpression | SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 | 1.27e-04 | 422 | 31 | 5 | M4308 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 1.41e-04 | 15 | 31 | 2 | MM402 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 1.43e-04 | 86 | 31 | 3 | M39247 | |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | 1.50e-04 | 437 | 31 | 5 | M4665 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 1.64e-04 | 235 | 31 | 4 | M5311 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.82e-04 | 17 | 31 | 2 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.82e-04 | 17 | 31 | 2 | MM1297 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN | 2.00e-04 | 465 | 31 | 5 | M9192 | |
| Coexpression | MENON_FETAL_KIDNEY_9_ENDOTHELIAL_CELLS | 2.38e-04 | 102 | 31 | 3 | M39259 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1 | 2.41e-04 | 260 | 31 | 4 | M1273 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1 | 2.52e-04 | 263 | 31 | 4 | MM998 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 2.62e-04 | 493 | 31 | 5 | M19391 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 3.05e-04 | 111 | 31 | 3 | M45685 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 3.19e-04 | 807 | 31 | 6 | M16651 | |
| Coexpression | TBK1.DF_DN | 3.46e-04 | 286 | 31 | 4 | M2864 | |
| Coexpression | WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP | 4.32e-04 | 26 | 31 | 2 | M8924 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 4.41e-04 | 305 | 31 | 4 | M19875 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 4.42e-04 | 126 | 31 | 3 | M39132 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 5.39e-04 | 29 | 31 | 2 | M47987 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 5.39e-04 | 29 | 31 | 2 | MM17055 | |
| Coexpression | JAATINEN_HEMATOPOIETIC_STEM_CELL_UP | 5.48e-04 | 323 | 31 | 4 | M15107 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS | 5.64e-04 | 137 | 31 | 3 | M41743 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 5.64e-04 | 137 | 31 | 3 | M39241 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 6.42e-04 | 337 | 31 | 4 | MM16606 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 6.99e-04 | 33 | 31 | 2 | M9167 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN | 7.63e-04 | 152 | 31 | 3 | M16842 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 8.07e-04 | 155 | 31 | 3 | M39246 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 8.38e-04 | 362 | 31 | 4 | M39176 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN | 8.85e-04 | 160 | 31 | 3 | MM974 | |
| Coexpression | HUANG_FOXA2_TARGETS_DN | 9.27e-04 | 38 | 31 | 2 | M16701 | |
| Coexpression | PATIL_LIVER_CANCER | 9.84e-04 | 660 | 31 | 5 | M1195 | |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 1.02e-03 | 168 | 31 | 3 | M18811 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | 1.07e-03 | 1407 | 31 | 7 | M14427 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 1.19e-03 | 398 | 31 | 4 | M7514 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 1.20e-03 | 178 | 31 | 3 | M17079 | |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP | 1.28e-03 | 182 | 31 | 3 | M8126 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | 1.32e-03 | 705 | 31 | 5 | M1410 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 1.34e-03 | 185 | 31 | 3 | M42503 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 1.36e-03 | 46 | 31 | 2 | MM544 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 1.42e-03 | 47 | 31 | 2 | M1399 | |
| Coexpression | GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN | 1.45e-03 | 190 | 31 | 3 | M384 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 1.46e-03 | 421 | 31 | 4 | MM985 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN | 1.48e-03 | 48 | 31 | 2 | M1246 | |
| Coexpression | PRC2_EZH2_UP.V1_UP | 1.50e-03 | 192 | 31 | 3 | M2739 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 1.52e-03 | 193 | 31 | 3 | M6813 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 1.53e-03 | 426 | 31 | 4 | M9516 | |
| Coexpression | LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE | 1.54e-03 | 49 | 31 | 2 | M2899 | |
| Coexpression | GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 1.54e-03 | 194 | 31 | 3 | M8017 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 1.59e-03 | 196 | 31 | 3 | MM667 | |
| Coexpression | ROY_WOUND_BLOOD_VESSEL_UP | 1.60e-03 | 50 | 31 | 2 | M7337 | |
| Coexpression | GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP | 1.61e-03 | 197 | 31 | 3 | M3092 | |
| Coexpression | GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP | 1.63e-03 | 198 | 31 | 3 | M5580 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP | 1.63e-03 | 198 | 31 | 3 | M7046 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP | 1.63e-03 | 198 | 31 | 3 | M6232 | |
| Coexpression | GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP | 1.63e-03 | 198 | 31 | 3 | M4309 | |
| Coexpression | GSE17721_CTRL_VS_LPS_12H_BMDC_DN | 1.66e-03 | 199 | 31 | 3 | M3702 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN | 1.66e-03 | 199 | 31 | 3 | M9283 | |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP | 1.66e-03 | 199 | 31 | 3 | M6198 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP | 1.66e-03 | 199 | 31 | 3 | M8848 | |
| Coexpression | GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | 1.66e-03 | 199 | 31 | 3 | M9173 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.66e-03 | 199 | 31 | 3 | M5151 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN | 1.68e-03 | 200 | 31 | 3 | M3714 | |
| Coexpression | GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN | 1.68e-03 | 200 | 31 | 3 | M9055 | |
| Coexpression | GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_DN | 1.68e-03 | 200 | 31 | 3 | M6368 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A1 COL4A2 COL4A6 COL5A2 COL9A2 COL13A1 SSBP3 FOXA3 COL27A1 | 2.71e-05 | 1153 | 31 | 9 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 9.77e-05 | 769 | 31 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 1.21e-04 | 66 | 31 | 3 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_500 | 1.21e-04 | 66 | 31 | 3 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k3_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DPsm.Th, 4+ 8+ TCR-/lo FSClo, Thymus, avg-3 | 1.64e-04 | 73 | 31 | 3 | GSM399400_100 | |
| CoexpressionAtlas | alpha beta T cells, T.DP.Th, 4+ 8+ TCR-/lo 69-, Thymus, avg-3 | 1.92e-04 | 77 | 31 | 3 | GSM399391_100 | |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 2.29e-04 | 615 | 31 | 6 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 2.94e-04 | 89 | 31 | 3 | PCBC_ratio_MESO-30_from-OSK-L-l-p53KD_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_episomal_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 2.94e-04 | 89 | 31 | 3 | PCBC_ratio_MESO-30_from-episomal_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 3.20e-04 | 1245 | 31 | 8 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.58e-04 | 234 | 31 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 5.57e-11 | 192 | 31 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 2.08e-09 | 174 | 31 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 3.42e-09 | 189 | 31 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.53e-09 | 190 | 31 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 3.88e-09 | 193 | 31 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 4.00e-09 | 194 | 31 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.13e-09 | 195 | 31 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 4.66e-09 | 199 | 31 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-07 | 171 | 31 | 5 | f648789e6aefe508bb748401bf9b3cd830fb0ddf | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-07 | 180 | 31 | 5 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-07 | 180 | 31 | 5 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.60e-07 | 182 | 31 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.73e-07 | 185 | 31 | 5 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.78e-07 | 186 | 31 | 5 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-07 | 186 | 31 | 5 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-07 | 186 | 31 | 5 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.83e-07 | 187 | 31 | 5 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.83e-07 | 187 | 31 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.83e-07 | 187 | 31 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-07 | 188 | 31 | 5 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-07 | 191 | 31 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.03e-07 | 191 | 31 | 5 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-07 | 193 | 31 | 5 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.20e-07 | 194 | 31 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 2.25e-07 | 195 | 31 | 5 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-07 | 195 | 31 | 5 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-07 | 195 | 31 | 5 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.25e-07 | 195 | 31 | 5 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.31e-07 | 196 | 31 | 5 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 2.31e-07 | 196 | 31 | 5 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.37e-07 | 197 | 31 | 5 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.37e-07 | 197 | 31 | 5 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.37e-07 | 197 | 31 | 5 | 236a40eb6c08e1d179cf0fb5450b032975c5f6b6 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.37e-07 | 197 | 31 | 5 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.43e-07 | 198 | 31 | 5 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.43e-07 | 198 | 31 | 5 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.49e-07 | 199 | 31 | 5 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-07 | 199 | 31 | 5 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.49e-07 | 199 | 31 | 5 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 2.49e-07 | 199 | 31 | 5 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.49e-07 | 199 | 31 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 2.49e-07 | 199 | 31 | 5 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-07 | 199 | 31 | 5 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.49e-07 | 199 | 31 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 3'-GW_trimst-1.5|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-07 | 199 | 31 | 5 | 8e69d718ed5b05b08550973c33c92f0c6bfccc68 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-07 | 199 | 31 | 5 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.49e-07 | 199 | 31 | 5 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.55e-07 | 200 | 31 | 5 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-07 | 200 | 31 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.55e-07 | 200 | 31 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.55e-07 | 200 | 31 | 5 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.55e-07 | 200 | 31 | 5 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.17e-06 | 157 | 31 | 4 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.17e-06 | 157 | 31 | 4 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.28e-06 | 158 | 31 | 4 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 4.39e-06 | 159 | 31 | 4 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.50e-06 | 160 | 31 | 4 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.08e-06 | 165 | 31 | 4 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.08e-06 | 165 | 31 | 4 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-ILC3|Lung / Manually curated celltypes from each tissue | 5.33e-06 | 167 | 31 | 4 | 0614d077b47a87f726068615548d0b0a216627be | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 5.58e-06 | 169 | 31 | 4 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.85e-06 | 171 | 31 | 4 | 6a489a75eeab2a2d48d604682e93599c20a945fe | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.99e-06 | 172 | 31 | 4 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.13e-06 | 173 | 31 | 4 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.13e-06 | 173 | 31 | 4 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 6.41e-06 | 175 | 31 | 4 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.56e-06 | 176 | 31 | 4 | 2015539c58aa0bb118e111ffedd63dd9fe863bb1 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.56e-06 | 176 | 31 | 4 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 176 | 31 | 4 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 176 | 31 | 4 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.70e-06 | 177 | 31 | 4 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.70e-06 | 177 | 31 | 4 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.70e-06 | 177 | 31 | 4 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.86e-06 | 178 | 31 | 4 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 7.01e-06 | 179 | 31 | 4 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.32e-06 | 181 | 31 | 4 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.32e-06 | 181 | 31 | 4 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.48e-06 | 182 | 31 | 4 | ba066ff9029cc052b76e2330ec168cb2e9b7e498 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.48e-06 | 182 | 31 | 4 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.48e-06 | 182 | 31 | 4 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 7.65e-06 | 183 | 31 | 4 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-06 | 183 | 31 | 4 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-06 | 183 | 31 | 4 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | Endothelial-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 7.65e-06 | 183 | 31 | 4 | 2c3f2c25c38f0598b4787d2ec335efe00fdc9751 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 7.65e-06 | 183 | 31 | 4 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-06 | 183 | 31 | 4 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 7.81e-06 | 184 | 31 | 4 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.98e-06 | 185 | 31 | 4 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.15e-06 | 186 | 31 | 4 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.15e-06 | 186 | 31 | 4 | db4d9ac89cc1e55062ba888b3410b773340595dd | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.33e-06 | 187 | 31 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | E17.5-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.33e-06 | 187 | 31 | 4 | 1f358d02ec69d44dea2e2831af9473ed05dcf8cc | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.33e-06 | 187 | 31 | 4 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | E17.5-Endothelial-unknown_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.33e-06 | 187 | 31 | 4 | da885c26ccc5189b1ff1f607552e00a5c0e49e7e | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.51e-06 | 188 | 31 | 4 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 8.51e-06 | 188 | 31 | 4 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-06 | 188 | 31 | 4 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 8.51e-06 | 188 | 31 | 4 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 8.51e-06 | 188 | 31 | 4 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-06 | 189 | 31 | 4 | a1773ef8fe4518d8f3b17c6fb2c3ff3bbc4d79ad | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.37e-04 | 50 | 22 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Drug | GK-101 | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.34e-24 | 36 | 31 | 11 | CID000161853 |
| Drug | Madecassol | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 5.16e-23 | 46 | 31 | 11 | CID000108062 |
| Drug | d-indobufen | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.44e-22 | 50 | 31 | 11 | CID000044562 |
| Drug | ridogrel | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.32e-22 | 52 | 31 | 11 | CID005362391 |
| Drug | NSC49633 | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.93e-22 | 53 | 31 | 11 | CID000023340 |
| Drug | AC1LAKND | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.94e-21 | 62 | 31 | 11 | CID000470146 |
| Drug | BAPN | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 9.70e-21 | 71 | 31 | 11 | CID000001647 |
| Drug | malotilate | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 9.70e-21 | 71 | 31 | 11 | CID000004006 |
| Drug | AC1NMZ1B | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.85e-20 | 75 | 31 | 11 | CID005034185 |
| Drug | strontium ranelate | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.52e-20 | 77 | 31 | 11 | CID006918182 |
| Drug | halofuginone lactate | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 7.99e-20 | 85 | 31 | 11 | CID000062891 |
| Drug | 4-hydroxyproline | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.76e-19 | 91 | 31 | 11 | CID000000825 |
| Drug | ticlopidine | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 7.36e-19 | 103 | 31 | 11 | CID000005472 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL4A1 SMARCA2 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.40e-18 | 162 | 31 | 12 | CID000072363 |
| Drug | hydroxylysine | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.41e-18 | 109 | 31 | 11 | CID000001029 |
| Drug | AC1L1C2F | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.56e-18 | 110 | 31 | 11 | CID000001711 |
| Drug | PPACK | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.13e-18 | 113 | 31 | 11 | CID003036757 |
| Drug | AC1L9732 | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.35e-18 | 114 | 31 | 11 | CID000439300 |
| Drug | Tranilast sodium | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.60e-18 | 115 | 31 | 11 | CID000005527 |
| Drug | Selara | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 6.72e-18 | 125 | 31 | 11 | CID000150310 |
| Drug | DMSe | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.25e-17 | 132 | 31 | 11 | CID000020796 |
| Drug | pirfenidone | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.06e-17 | 138 | 31 | 11 | CID000040632 |
| Drug | DL-penicillamine | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.24e-17 | 139 | 31 | 11 | CID000004727 |
| Drug | PCR 4099 | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.24e-17 | 139 | 31 | 11 | CID000002806 |
| Drug | candesartan cilexetil | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 3.61e-17 | 145 | 31 | 11 | CID000002540 |
| Drug | khellin | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.30e-16 | 171 | 31 | 11 | CID000003828 |
| Drug | AC1L1DD6 | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 3.84e-16 | 179 | 31 | 11 | CID000002299 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 7.05e-16 | 189 | 31 | 11 | CID000001413 |
| Drug | foscarnet | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 7.47e-16 | 190 | 31 | 11 | CID000003414 |
| Drug | AC1Q6PCP | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 6.23e-15 | 230 | 31 | 11 | CID000005267 |
| Drug | prostacyclin sodium salt | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.57e-14 | 250 | 31 | 11 | CID000000159 |
| Drug | hyaluronan | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.74e-14 | 263 | 31 | 11 | CID000024759 |
| Drug | silibinin | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 6.61e-14 | 285 | 31 | 11 | CID000005213 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.91e-13 | 314 | 31 | 11 | CID000447989 |
| Drug | AC1L18QD | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 2.78e-13 | 325 | 31 | 11 | CID000000213 |
| Drug | AC1L1KMJ | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 MARCO COL27A1 | 5.98e-13 | 476 | 31 | 12 | CID000030956 |
| Drug | losartan | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.44e-12 | 378 | 31 | 11 | CID000003961 |
| Drug | colchine | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.66e-12 | 383 | 31 | 11 | CID000002833 |
| Drug | chondroitin sulfate | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 3.75e-12 | 413 | 31 | 11 | CID000024766 |
| Drug | Y-27632 | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 8.18e-12 | 444 | 31 | 11 | CID000005711 |
| Drug | aspirin | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 1.04e-10 | 563 | 31 | 11 | CID000002244 |
| Drug | LMWH | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 5.86e-10 | 663 | 31 | 11 | CID000000772 |
| Drug | NC-4 | 3.49e-09 | 44 | 31 | 5 | CID006420119 | |
| Drug | LS-63783 | COL4A1 COL4A3 COL4A6 COL24A1 COL9A2 COL10A1 COL22A1 COL13A1 COL17A1 COL21A1 COL27A1 | 4.41e-09 | 804 | 31 | 11 | CID000000231 |
| Drug | L-3,4-dehydroproline | 2.87e-06 | 73 | 31 | 4 | CID000094284 | |
| Drug | CP-331 | 5.38e-06 | 3 | 31 | 2 | CID000130967 | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; HL60; HT_HG-U133A | 6.52e-06 | 197 | 31 | 5 | 3008_UP | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 6.85e-06 | 199 | 31 | 5 | 6069_UP | |
| Drug | pyridinoline | 9.67e-06 | 99 | 31 | 4 | CID000105068 | |
| Drug | 1zd2 | 3.12e-05 | 45 | 31 | 3 | CID004149241 | |
| Drug | carmustine; Down 200; 100uM; PC3; HT_HG-U133A | 1.34e-04 | 194 | 31 | 4 | 6883_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; HL60; HT_HG-U133A | 1.34e-04 | 194 | 31 | 4 | 2735_DN | |
| Drug | Azapropazone [13539-59-8]; Up 200; 13.4uM; HL60; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 3143_UP | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.48e-04 | 199 | 31 | 4 | 4649_DN | |
| Drug | C75; Up 200; 10uM; MCF7; HT_HG-U133A | 1.48e-04 | 199 | 31 | 4 | 6394_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.51e-04 | 200 | 31 | 4 | 2190_UP | |
| Drug | NOC 18 | 2.13e-04 | 16 | 31 | 2 | ctd:C093285 | |
| Drug | dermatan sulfate | 2.17e-04 | 220 | 31 | 4 | CID000032756 | |
| Drug | 351A | 3.36e-04 | 20 | 31 | 2 | CID000122144 | |
| Drug | alpha-methyl-D-mannoside | 5.22e-04 | 116 | 31 | 3 | CID000002108 | |
| Disease | collagen disease (implicated_via_orthology) | 1.87e-07 | 12 | 29 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | Developmental Porencephaly | 9.33e-07 | 2 | 29 | 2 | C4082301 | |
| Disease | Post-traumatic Porencephaly | 9.33e-07 | 2 | 29 | 2 | C3698507 | |
| Disease | Congenital porencephaly | 9.33e-07 | 2 | 29 | 2 | C0302892 | |
| Disease | Porencephaly | 9.33e-07 | 2 | 29 | 2 | C4082173 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 9.33e-07 | 2 | 29 | 2 | C4551998 | |
| Disease | PORENCEPHALY, FAMILIAL | 9.33e-07 | 2 | 29 | 2 | C1867983 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 9.33e-07 | 2 | 29 | 2 | C3281105 | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 2.80e-06 | 3 | 29 | 2 | cv:C3281105 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 2.80e-06 | 3 | 29 | 2 | 614519 | |
| Disease | Abortion, Tubal | 3.90e-06 | 109 | 29 | 4 | C0000822 | |
| Disease | Early Pregnancy Loss | 3.90e-06 | 109 | 29 | 4 | C3830362 | |
| Disease | Miscarriage | 3.90e-06 | 109 | 29 | 4 | C4552766 | |
| Disease | Spontaneous abortion | 3.90e-06 | 109 | 29 | 4 | C0000786 | |
| Disease | myopathy (implicated_via_orthology) | 1.43e-05 | 48 | 29 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.93e-05 | 53 | 29 | 3 | C4707243 | |
| Disease | arterial stiffness measurement | 3.42e-05 | 64 | 29 | 3 | EFO_0004517 | |
| Disease | intraocular pressure measurement | 1.26e-04 | 509 | 29 | 5 | EFO_0004695 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.58e-04 | 19 | 29 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Myasthenic Syndromes, Congenital | 2.54e-04 | 24 | 29 | 2 | C0751882 | |
| Disease | cortical surface area measurement | 2.60e-04 | 1345 | 29 | 7 | EFO_0010736 | |
| Disease | Nephrotic Syndrome | 3.22e-04 | 27 | 29 | 2 | C0027726 | |
| Disease | Cerebral Hemorrhage | 3.47e-04 | 28 | 29 | 2 | C2937358 | |
| Disease | spontaneous coronary artery dissection | 4.26e-04 | 31 | 29 | 2 | EFO_0010820 | |
| Disease | neuroimaging measurement | 5.18e-04 | 1069 | 29 | 6 | EFO_0004346 | |
| Disease | cortical thickness | 6.40e-04 | 1113 | 29 | 6 | EFO_0004840 | |
| Disease | childhood gender nonconformity | 8.21e-04 | 43 | 29 | 2 | EFO_0020103 | |
| Disease | carotid artery intima media thickness | 9.37e-04 | 450 | 29 | 4 | EFO_0007117 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQKGSVGDPGMEGPM | 606 | Q9UMD9 | |
| MRGEPGFMGTPGKVG | 1326 | Q14031 | |
| PGAMGPRGPKGHMGE | 206 | Q01955 | |
| GDPGLPGDMGKKGEM | 1071 | Q01955 | |
| GFGGMRPGFEGMPHN | 281 | Q9NP70 | |
| SPHAMGQGMGGLPPG | 331 | P54259 | |
| GFRGSQGMPGMPGLK | 806 | P08572 | |
| GMDGFQGMPGLKGRP | 926 | P08572 | |
| IPGFPGSKGEMGVMG | 871 | P02462 | |
| GSKGEMGVMGTPGQP | 876 | P02462 | |
| GFPGFPGMLGQKGEM | 201 | Q9Y215 | |
| GPSTAMPGGHGDMHG | 406 | P15884 | |
| MPGGHGDMHGIIGPS | 411 | P15884 | |
| GPKGETGPHGYKGMV | 241 | Q14055 | |
| AKPHNPGFGMGGPMH | 616 | Q12906 | |
| GFPGLHGMPGSKGEM | 521 | Q96P44 | |
| KGAPGMPGLMGSNGS | 631 | Q96P44 | |
| KGMAGGHGPDGPKGS | 731 | P05997 | |
| GKRGKMGMPGFPGVF | 781 | Q8IZC6 | |
| IGYPGPKGMKGLMGS | 831 | Q8IZC6 | |
| PKGMKGLMGSVGEPG | 836 | Q8IZC6 | |
| GQPGDSGEMGFPGMA | 1526 | Q8IZC6 | |
| GEKGEMGVAGPMGLP | 481 | Q8NFW1 | |
| GAPGLQGHKGAMGMP | 151 | Q9UEW3 | |
| QGHKGAMGMPGAPGP | 156 | Q9UEW3 | |
| RKGERGMPGMPGKHG | 316 | Q5TAT6 | |
| GMPGMPGKHGAKGAP | 321 | Q5TAT6 | |
| GMFPGKGGMVAPGMT | 421 | Q9Y238 | |
| LHGPAGMAPRGMPGL | 96 | Q96NZ1 | |
| GSGGGQPKAGMPAME | 206 | Q8NC24 | |
| DGPMGGLGGMESHHM | 291 | P81877 | |
| SDGPMGGMGGMEPHH | 316 | Q9BWW4 | |
| GGMGGMEPHHMNGSL | 321 | Q9BWW4 | |
| CGSMKGTGMRPPHPG | 91 | P51531 | |
| GYGAPGPGLVHGKEM | 91 | P55318 | |
| PLGHGFGLAHPGMMQ | 1071 | Q0VD83 | |
| PAGAKGMPGHNGEAG | 426 | Q03692 | |
| KGDQGLSGLMGPPGM | 551 | Q17RW2 | |
| LSGLMGPPGMQGDKG | 556 | Q17RW2 | |
| GTMPMAGGIPGGVHN | 1586 | Q8IZH2 | |
| GGPGGAEGPMAKKHA | 186 | Q16763 | |
| LMGSMGAGKGPQGPG | 561 | Q96QC0 | |
| GMGMDPSTAGGVPFG | 56 | Q8ND25 |